Geographical variation in opioid prescribing and opioid-related mortality in Ontario

No abstract available.

View Source

Information

Citation

Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, Mamdani M. Healthc Q. 2011;14(1):22-4.

View Source

Contributing ICES Scientists

Research Programs

Chronic Disease & Pharmacotherapy

Associated Topics

Pharmacoepidemiology and drug safety

Associated Sites

Discover More

Journal Article

09/04/2024

Characteristics of opioid toxicity deaths among adolescents and young adults in Ontario prior to and during the COVID-19 pandemic

Akbar S, Iacono A, Yang J, Antoniou T, Juurlink D, Sheikh H, Kurdyak P, Wu F, Cheng C, Leece P, Kolla G, Emblem J, Shearer D, Gomes T. J Adolesc Health. 2024; Apr 9 [Epub ahead of print].

Journal Article

04/04/2024

Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: a population-based study

Antoniou T, McCormack D, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2024; Apr 4 [Epub ahead of print].

Journal Article

02/04/2024

Population trends of new prescriptions for antihyperglycemics and antihypertensives between 2014 and 2022

Yu AYX, Austin PC, Jackevicius CA, Chu A, Holodinsky JK, Hill MD, Kamal N, Kumar M, Lee DS, Vyas MV, Joundi RA, Khan NA, Kapral MK, McNaughton CD. J Am Heart Assoc. 2024; Apr 2 [Epub ahead of print].

See All